Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1346 of 6351
-
Could a Placenta-Based bandage heal stubborn leg wounds?
Disease control Not yet recruitingThis is a randomized controlled trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating venous leg ulcers.
Sponsor: NuScience Medical Biologics, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Triple threat: new combo therapy aims to tackle rare lung disease
Disease control Not yet recruitingThe study aims to see how 24 weeks of triple therapy-an endothelin receptor antagonist (ERA), a phosphodiesterase-5 inhibitor (PDE5i), and sotatercept-affects pulmonary vascular resistance (PVR) in patients with newly diagnosed pulmonary arterial hypertension (PAH). SIRIUS is a 2…
Phase 2 • Sponsor: Philipps University Marburg • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a simple blood test spot hidden cancers? new study aims to find out
Diagnosis Not yet recruitingThe purpose of this research study is to evaluate the possible benefits of screening with an investigational, but commercially available blood test designed to detect many types of cancer. The name of the screening blood test being studied is: -GRAIL Galleri MCED test
Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
New hope for stubborn eye disease: arthritis drug shows promise
Disease control Not yet recruitingThe aim of the study is to evaluate the efficacy of Baricitinib, a JAK1 and 2 inhibitor, in the management of non-infectious non-anterior uveitis refractory to at least one line of biotherapy (anti-TNF alpha, tocilizumab) after 6 months of treatment
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Does this pain device really work? a blinded trial aims to find out
Symptom relief Not yet recruitingNeuropathic pain affects 6-10% of the global population and is poorly managed - current drug treatments succeed in only \~25% of patients. Spinal cord stimulation (SCS) modulates pain by electrically stimulating spinal dorsal column fibres. The newer paresthesia-free mode (PF-SCS…
Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Personalized dosing may boost lupus kidney remission
Disease control Not yet recruitingSystemic lupus erythematosus (SLE) is an inflammatory, chronic, and multisystem autoimmune disease characterized by periods of activity and remission. Lupus nephritis (LN) is the most frequent renal complication and is associated with high morbidity, manifesting as nephritic or n…
Sponsor: Federal University of Maranhao • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Cord blood cells aim to tame deadly transplant complication
Disease control Not yet recruitingThe purpose of this study is to determine the efficacy and safety of CK0802 Tregs for treatment of refractory GVHD (graft-versus-host disease)
Phase 1/2 • Sponsor: Cellenkos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can a common cholesterol pill flush out 'forever chemicals' from veterans' bodies?
Disease control Not yet recruitingThe goal of this study is to test the efficacy and feasibility of Colesevelam administration (50% of the recommended dose) to reduce serum PFAS concentration in the Veteran population who have serum PFAS levels that exceed the National Academies Science criteria (PFASsix \> 20 ng…
Phase 2 • Sponsor: University of Rhode Island • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could an arthritis drug lift the fog of Treatment-Resistant depression?
Symptom relief Not yet recruitingClinical trial aimed at evaluating whether a single infusion of tocilizumab, a medication that blocks the action of an inflammatory molecule called interleukin-6 (IL-6), can reduce symptoms of treatment-resistant major depression compared to placebo in non-hospitalized patients.
Phase 2 • Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Could a daily shot help control rare lung disease?
Disease control Not yet recruitingThe primary objective of this study is to compare the efficacy, safety, and tolerability of tiprelestat plus Standard of Care (SOC) compared with placebo plus SOC in patients with World Health Organization (WHO) functional class II-IV pulmonary arterial hypertension (PAH).
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Gentle moves, big heart benefits? new study tests ancient exercise after surgery
Disease control Not yet recruiting1. To evaluate the efficacy and safety of the Baduanjin exercise programme in patients following coronary revascularisation surgery; 2. To develop a traditional Chinese medicine (TCM) rehabilitation protocol and evaluation system for patients following coronary revascularisation …
Sponsor: Liu Qiang • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Heart surgery without opioids: a safer path to recovery?
Symptom relief Not yet recruitingThe goal of this clinical trial is to compare the effect of opioid-free anesthesia on the intensity of acute and chronic postoperative pain in patients undergoing cardiac surgery. The study will also evaluate the safety of opioid-free anesthesia in this patient population. The m…
Sponsor: Clinical Centre of Serbia • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Could melatonin help save newborn brains after oxygen deprivation?
Disease control Not yet recruitingCOMPARISON OF OUTCOME OF HYPOXIC ISCHEMIC ENCEPHALOPATHY MANAGED WITH COMBINATION OF MAGNESIUM SULPHATE AND MELATONIN VERSUS MAGNESIUM SULPHATE ALONE Participants of group A will have 3 doses of MgSO4 infusion at rate of 250mg/kg per day intravenous over 1hour on day 0,1,2 Partic…
Phase 3 • Sponsor: University of Child Health Sciences and Children's Hospital, Lahore • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for bile duct cancer: drug duo targets tough tumors
Disease control Not yet recruitingBiliary tract carcinoma (BTC), including cholangiocarcinoma and gallbladder cancer, is a highly aggressive digestive system malignancy with limited treatment options after failure of first-line standard chemotherapy. This open-label, single-arm, Phase II exploratory study aims t…
Phase 2 • Sponsor: HuiKai Li • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a maintenance drug keep lymphoma at bay? new trial aims to find out.
Disease control Not yet recruitingThis is a multicenter, phase 2, randomized trial to compare rituximab maintenance with observation after rituximab and lenalidomide (R2) induction therapy in patients with previously untreated marginal zone lymphoma. Patients who achieve complete response or partial response afte…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Sound waves instead of needles: new device targets back pain without piercing skin
Symptom relief Not yet recruitingOur study aims to investigate the safety and efficacy of high intensity focused ultrasound in the management of low back pain due to sacroiliitis. Sacroiliitis is the inflammation of a joint in the lowest part of the spin and it is one of the cause of low back; the diagnosis is e…
Sponsor: Federico II University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could remote hand exercises ease Parkinson's symptoms?
Disease control Recruiting nowThe aim of this study is to compare the effects of tele-rehabilitation-based synchronous and asynchronous dual-task upper extremity training with clinical based dual-task upper extremity training and conventional single-task upper extremity training in patients with Parkinson's d…
Sponsor: Saglik Bilimleri Universitesi • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Simple CT scan could reveal hidden heart risks in HIV patients
Knowledge-focused Not yet recruitingThe risk of atherosclerotic cardiovascular disease is increased in people with HIV infection, including young patients and those with few traditional cardiovascular risk factors. The increased risk of cardiovascular disease among people living with HIV is due to accelerated ather…
Sponsor: Instituto Mexicano del Seguro Social • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
AI dentists? chatbots take on root canal diagnosis
Diagnosis Not yet recruitingThis diagnostic test accuracy (DTA) study aims to evaluate the diagnostic performance of educated large language models (Educated ChatGPT (GPT-5.5 Pro), Educated Gemini 3.1 Pro, and Educated Claude Opus 4.7) in endodontic practice. Their ability to establish pulpal and periapical…
Sponsor: Cairo University • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
Can a two-drug combo better tame prostate trouble?
Symptom relief Recruiting nowThis study aims to evaluate the short-term impact and clinical outcomes of tamsulosin monotherapy versus combination therapy with tamsulosin plus tadalafil (2.5 mg vs. 5 mg) on lower urinary tract symptoms (LUTS) severity and patient quality of life in men with benign prostatic h…
Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC